Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

NanoSphere Health Sciences’ Evolve Formulas NanoSerum Shows Promise According to Users -- CFN Media


Posted on: 11 Jul 18

SEATTLE, July 11, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article covering NanoSphere Health Sciences Inc. (CSE:NSHS) (CSE:NSHS.CN) (CNSX:NSHS) (OTC:NSHSF) and how the company is on the cutting-edge of cannabinoid delivery science with its patented NanoSphere Delivery System™. Its cannabis brand, Evolve Formulas, has commercialized this delivery platform through its pioneering product, NanoSerum™, which uses one-of-a-kind nanotechnology to encapsulate cannabinoids in lipid membranes for direct delivery through the skin and into the circulatory system within minutes for rapid and effective relief from pain, inflammation and anxiety. The product has been called life-changing by some, opening new doors for people exploring alternatives to more conventional treatments.

David Sutton, COO of NanoSphere, knew they had something special after his mother tried an early formulation of Evolve Formulas NanoSerum™ to help ease symptoms of Crohn’s disease.

“When we were in the initial R&D stage of applying our technology to cannabis, we had a couple of prototypes, and my father - CEO of NanoSphere - brought one home. My mom had a Crohn's attack about to begin, and when that happens, she gets a lot of spasms in her GI tract, and it's extraordinarily painful, and it lasts for up to 12 hours. My father said, ‘Why don't you just try this?’ Not even really thinking about it, just trying to give her some relief. She rubbed it on her stomach and her abdomen, and within a minute her spasms stopped, and they did not return.”

Sutton calls the effects “incredible,” stating that no mainstream medication he’d heard of had ever been able to do what the NanoSerum™ did.

“From there, we went full force into creating the best product we could,” he explains.

Emily Anderson, a 21-year-old college student, began using NanoSerum™ after being told about it by a friend. Anderson has suffered from extreme PTSD following a sexual assault in 2015.

“It was the only thing that ever actually worked,” she tells CFN Media. “I’ve been on so many different medications, the majority of which had terrible side-effects, but NanoSerum™ has given me my life back.” Anderson states she uses the product for both anxiety and to help combat shoulder pain that she believes is exacerbated by her PTSD.

“NanoSerum™ is anxiety relieving, but the pain relief in my shoulders is the most important benefit. Anxiety causes loads of knots in my shoulders and Evolve Formulas products help to soothe the pain.”

Sutton says it’s stories like these that keep him motivated to continue to develop NanoSphere’s technology and the Evolve Formulas product line. He mentions an elderly patient with degenerative disc disease who was able to completely wean himself off of fentanyl, an extremely dangerous opioid painkiller that is blamed for the accidental overdose deaths of both Prince and Tom Petty.

“More and more of these stories are coming out. It's inspiring to hear that you're helping create something that's really improving people's lives.”

He also mentions a woman suffering from arthritis so severe she couldn’t use her hand. She had tried other cannabis topicals with no success.

“Within minutes of trying our product, she was able to move her hand again, which she hadn't been able to do previously,” Sutton explains. “After consistent usage, she can actually use her hand. Not only move it, but write with it again, and she said it's been years since she's been able to do that.”

These stories are just a few of the many being told every day and the team at NanoSphere Health Sciences wants to ensure they continue. Pre-sales of their new Evolve Formulas CBD NanoSerum™ have recently begun and intranasal and intraoral products are currently in development. Initial tests on the intranasal spray show onset within 80 seconds, which Sutton believes will be crucial for patients who need immediate results.

“We believe the intranasal will be beneficial to people with PTSD, just as people with arthritis find our NanoSerum™ helpful. We’re very excited to see how it’s going to impact lives.”

Learn more about NanoSphere Health Sciences Inc. (CSE:NSHS) by visiting their website or downloading their investor presentation.

Please follow the link to read the full article: http://www.cannabisfn.com/nanosphere-health-sciences-evolve-formulas-nanoserum-shows-promise-according-users/

About CFN Media

CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

Frank Lane
206-369-7050
Flane@cannabisfn.com 

GlobeNewswire
globenewswire.com

Last updated on: 11/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.